Correlation of Health-Related Quality of Life in Clinically Stable Outpatients with Schizophrenia

References

• Millier A, Clay E, Charaf I, et al. Patient reported outcomes instruments in schizophrenia : a review of psychometric properties. Open J Med Psychol. 2014;2014(1):141–156. doi:10.4236/ojmp.2014.32017
   Google Scholar
• Awada G, Voruganti LN, Heslegrave RJ. A conceptual model of quality of life in schizophrenia: description and preliminary clinical validation. Qual Life Res. 1997;6(1):21–26. doi:10.1023/a:10264093266909062438
   PubMed Web of Science ®Google Scholar
• Awad AG, Voruganti LNP. Measuring quality of life in patients with schizophrenia: an update. Pharmacoeconomics. 2012;30(3):183–195. doi:10.2165/1159447022263841
   PubMed Web of Science ®Google Scholar
• Seow LSE, Tan THG, Abdin E, Chong SA, Subramaniam M. Comparing disease-specific and generic quality of life measures in patients with schizophrenia. Psychiatry Res. 2019;273(January):387–393. doi:10.1016/j.psychres.2019.01.03430682561
   PubMed Web of Science ®Google Scholar
• Papaioannou D, Brazier J, Parry G. How valid and responsive are generic health status measures, such as EQ-5D and SF-36, in Schizophrenia? A systematic review. Value Heal. 2011;14(6):907–920. doi:10.1016/j.jval.2011.04.006
   PubMed Web of Science ®Google Scholar
• Brazier J, Connell J, Papaioannou D, et al. A systematic review, psychometric analysis and qualitative assessment of generic preference-based measures of health in mental health populations and the estimation of mapping functions from widely used specific measures. Health Technol Assess (Rockv). 2014;18(34):1–188. doi:10.3310/hta18340
   PubMed Web of Science ®Google Scholar
• Auquier P, Simeoni MC, Sapin C, et al. Development and validation of a patient-based health-related quality of life questionnaire in schizophrenia: the S-QoL. Schizophr Res. 2003;63:137–149. doi:10.1016/S0920-9964(02)00355-912892868
   PubMed Web of Science ®Google Scholar
• Prieto L, Sacristán JA, Hormaechea JA, Casado A, Badia X, Gómez JC. Psychometric validation of a generic health-related quality of life measure (EQ-5D) in a sample of schizophrenic patients. Curr Med Res Opin. 2004;20:827–835. doi:10.1185/03007990412500367415200739
   PubMed Web of Science ®Google Scholar
• Wilkinson G, Hesdon B, Wild D, et al. Self-report quality of life measure for people with schizophrenia: the SQLS. Br J Psychiatry. 2000;177(JUL):42–46. doi:10.1192/bjp.177.1.4210945087
   PubMed Web of Science ®Google Scholar
• Whitehorn D, Milliken H, Ronson K, Rui Q. 0230 THE SF-36 AS A COMPONENT OF A CLINICAL ASSESSMENT BATTERY IN EARLY PSYCHOSIS. Schizophr Res. 2006;86:S105. doi:10.1016/s0920-9964(06)70313-9
   Web of Science ®Google Scholar
• Revicki DA, Genduso LA, Hamilton SH, Ganoczy D, Beasley CM. Olanzapine versus haloperidol in the treatment of schizophrenia and other psychotic disorders: quality of life and clinical outcomes of a randomized clinical trial. Qual Life Res. 1999;8:417–426. doi:10.1023/A:100895892584810474283
   PubMed Web of Science ®Google Scholar
• Reine G, Simeoni M-C, Auquier P, Loundou A, Aghababian V, Lancon C. Assessing health-related quality of life in patients suffering from schizophrenia: a comparison of instruments. Eur Psychiatry. 2005;20:510–519. doi:10.1016/j.eurpsy.2005.05.00916139488
   PubMed Web of Science ®Google Scholar
• Meijer CJ, Schene AH, Koeter MWJ. Quality of life in schizophrenia measured by the MOS SF-36 and the lancashire quality of life profile: a comparison. Acta Psychiatr Scand. 2002;105:293–300. doi:10.1034/j.1600-0447.2002.1198.x11942934
   PubMed Web of Science ®Google Scholar
• Barton GR, Hodgekins J, Mugford M, Jones PB, Croudace T, Fowler D. Measuring the benefits of treatment for psychosis: validity and responsiveness of the EQ–5D. Br J Psychiatry. 2009;195:170–177. doi:10.1192/bjp.bp.108.05738019648552
   PubMed Web of Science ®Google Scholar
• Katschnig H. Schizophrenia and quality of life. Acta Psychiatr Scand Suppl. 2000;102:33–37. doi:10.1034/j.1600-0447.2000.00006.x
   Google Scholar
• Gray R, Leese M, Bindman J, et al. Adherence therapy for people with schizophrenia: European multicentre randomised controlled trial. Br J Psychiatry. 2006;189:508–514. doi:10.1192/bjp.bp.105.01948917139034
   PubMed Web of Science ®Google Scholar
• Crawford MJ, Killaspy H, Barnes TRE, et al. Group art therapy as an adjunctive treatment for people with schizophrenia: multicentre pragmatic randomised trial. BMJ. 2012;344:e846–e846. doi:10.1136/bmj.e84622374932
   PubMed Web of Science ®Google Scholar
• Mulhern B, Mukuria C, Barkham M, et al. Using generic preference-based measures in mental health: psychometric validity of the EQ-5D and SF-6D. Br J Psychiatry. 2014;205:236–243. doi:10.1192/bjp.bp.112.12228324855127
   PubMed Web of Science ®Google Scholar
• Boyer L, Baumstarck K, Boucekine M, Blanc J, Lançon C, Auquier P. Measuring quality of life in patients with schizophrenia: an overview. Expert Rev Pharmacoecon Outcomes Res. 2013;13(3):343–349. doi:10.1586/erp.13.1523763531
   PubMed Web of Science ®Google Scholar
• Livneh H, Lott SM, Antonak RF. Patterns of psychosocial adaptation to chronic illness and disability: a cluster analytic approach. Psychol Health Med. 2004;9(4):411–430 20. doi:10.1080/1354850042000267030
   Google Scholar
• Rabin R, de Charro F. EQ-SD: a measure of health status from the EuroQol Group. Ann Med. 2001;33(5):337–343. doi:10.3109/0785389010900208711491192
   PubMed Web of Science ®Google Scholar
• Ware J, Sherbourne C, The MOS 36-ltem short-form health survey (SF-36): I. Conceptual framework and item selection. Med Care. 1992;30(6):473–483. doi:10.1097/00005650-199206000-000021593914
   PubMed Web of Science ®Google Scholar
• Haro JM, Altamura C, Corral R, et al. Understanding the impact of persistent symptoms in schizophrenia: cross-sectional findings from the pattern study. Schizophr Res. 2015;169:1–3. doi:10.1016/j.schres.2015.09.00126481614
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders; Elsevier Inc 2000. doi:10.1016/B978-1-4377-2242-0.00016-X
   Google Scholar
• Lecrubier Y, Sheehan DV, Weiller E, et al. The Mini International Neuropsychiatric Interview (MINI). A short diagnostic structured interview: reliability and validity according to the CIDI. Eur Psychiatry. 1997;12(5):224–231. doi:10.1016/S0924-9338(97)83296-8
   Web of Science ®Google Scholar
• Kay SR, Fiszbein AOL, Positive T. Negative Syndrome Scale for schizophrenia. Schizophr Bull. 1987;13(2):261–276. doi:10.1093/schbul/13.2.2613616518
   PubMed Web of Science ®Google Scholar
• Lindenmayer JP, Grochowski S, Hyman RB. Five factor model of schizophrenia: replication across samples. Schizophr Res. 1995;14(3):229–234. doi:10.1016/0920-9964(94)00041-67766534
   PubMed Web of Science ®Google Scholar
• Jenkinson C, Coulter A, Wright L. Short form 36 (SF 36) health survey questionnaire: normative data for adults of working age. BMJ. 1993;306(Sf36):1437–1440. doi:10.1136/bmj.306.6890.14378518639
   PubMed Web of Science ®Google Scholar
• Dolan P, Gudex C, Kind P, Williams A. A social tariff for EuroQol: results from a UK general population survey. Work Pap. 1995.
   Google Scholar
• Linde L, Sørensen J, Ostergaard M, Hørslev-Petersen K, Hetland ML. Health-related quality of life: validity, reliability, and responsiveness of SF-36, 15D, EQ-5D [corrected] RAQoL, and HAQ in patients with rheumatoid arthritis. J Rheumatol. 2008;35(8):1528–1537.18484697
   PubMed Web of Science ®Google Scholar
• Fransen M, Edmonds J. Reliability and validity of the EuroQol in patients with osteoarthritis of the knee. Rheumatol. 1999;38:807–813. doi:10.1093/rheumatology/38.9.807
   PubMed Web of Science ®Google Scholar
• Jenkinson C, Wright L. Coulter a. Criterion validity and reliability of the SF-36 in a population sample. Qual Life Res. 1994;3(1):7–12. doi:10.1007/BF006478438142947
   PubMed Web of Science ®Google Scholar
• Pitkanen A, Valimaki M, Endicott J, et al. Assessing quality of life in patients with schizophrenia in an acute psychiatric setting: reliability, validity and feasibility of the EQ-5D and the Q-LES-Q. Nord J Psychiatry. 2012;66(1):19–25. doi:10.3109/08039488.2011.59309921770824
   PubMed Web of Science ®Google Scholar
• Tunis SL, Croghan TW, Heilman DK, Johnstone BM, Obenchain RL. Reliability, validity, and application of the medical outcomes study 36-item short-form health survey (SF-36) in schizophrenic patients treated with olanzapine versus haloperidol. Med Care. 1999;37(7):678–691. doi:10.1097/00005650-199907000-0000810424639
   PubMed Web of Science ®Google Scholar
• Cronbach LJ, Meehl PE. Construct validity in psychological tests. Psychol Bull. 1955;52:281–302. doi:10.1037/h004095713245896
   PubMed Web of Science ®Google Scholar
• Bland JM, Altman DG. Statistics notes: cronbach’s alpha. BMJ. 1997;314:572. doi:10.1136/bmj.314.7080.5729055718
   PubMed Web of Science ®Google Scholar
• McDonald JF, Moffitt RA. The Uses of Tobit Analysis. Rev Econ Stat. 1980;62:318. doi:10.2307/1924766
   Web of Science ®Google Scholar
• Chou CY, Ma MC, Yang TT. Determinants of subjective health-related quality of life (HRQoL) for patients with schizophrenia. Schizophr Res. 2014;154:83–88. doi:10.1016/j.schres.2014.02.01124613000
   PubMed Web of Science ®Google Scholar
• Arraras JI, Ibañez B, Pereda N, Iribarren S, Basterra I. The association of clinical insight and depression with quality of life in schizophrenia. Psychiatry Res. 2019;(February):0–1. doi:10.1016/j.psychres.2019.02.069
   Web of Science ®Google Scholar
• Vrbova K, Prasko J, Ociskova M, et al. Quality of life, self-stigma, and hope in schizophrenia spectrum disorders: a cross-sectional study. Neuropsychiatr Dis Treat. 2017. doi:10.2147/NDT.S122483
   Web of Science ®Google Scholar
• Hasan AAH. The correlation between the quality of life and clinical variables among outpatients with schizophrenia. Psychiatry Res. 2019;271(September2018):39–45. doi:10.1016/j.psychres.2018.09.06230465980
   PubMed Web of Science ®Google Scholar
• Huppert JD, Weiss KA, Lim R, Pratt S, Smith TE. Quality of life in schizophrenia: contributions of anxiety and depression. Schizophr Res. 2001;51:171–180. doi:10.1016/S0920-9964(99)00151-611518637
   PubMed Web of Science ®Google Scholar
• Meijer CJ, Koeter MWJ, Sprangers MAG, Schene AH. Predictors of general quality of life and the mediating role of health related quality of life in patients with schizophrenia. Soc Psychiatry Psychiatr Epidemiol. 2009;44:361–368. doi:10.1007/s00127-008-0448-418974910
   PubMed Web of Science ®Google Scholar
• Cohen CI, Vengassery A, Garcia Aracena EF. A longitudinal analysis of quality of life and associated factors in older adults with schizophrenia spectrum disorder. Am J Geriatr Psychiatry. 2017;25:755–765. doi:10.1016/j.jagp.2017.01.01328431868
   PubMed Web of Science ®Google Scholar
• Fervaha G, Agid O, Takeuchi H, Foussias G, Remington G. Clinical determinants of life satisfaction in chronic schizophrenia: data from the CATIE study. Schizophr Res. 2013;151:203–208. doi:10.1016/j.schres.2013.10.02124183751
   PubMed Web of Science ®Google Scholar
• Wartelsteiner F, Mizuno Y, Frajo-Apor B, et al. Quality of life in stabilized patients with schizophrenia is mainly associated with resilience and self-esteem. Acta Psychiatr Scand. 2016;134:360–367. doi:10.1111/acps.1262827497263
   PubMed Web of Science ®Google Scholar
• Nakagawa S, Hayashi N. Clinical correlates of objective and subjective quality of life among middle-aged and elderly female inpatients with chronic schizophrenia. Asian J Psychiatr. 2013;6:389–393. doi:10.1016/j.ajp.2013.03.01524011685
   PubMedGoogle Scholar
• Xiang YT, Hou YZ, Yan F, et al. Quality of life in community-dwelling patients with schizophrenia in China. J Nerv Ment Dis. 2012;200:584–587. doi:10.1097/NMD.0b013e31825bfc7122759934
   PubMed Web of Science ®Google Scholar
• Karow A, Moritz S, Lambert M, Schoder S, Krausz M. PANSS syndromes and quality of life in schizophrenia. Psychopathology. 2005;38:320–326. doi:10.1159/00008892116224206
   PubMed Web of Science ®Google Scholar
• Alessandrini Lançon C, Fond G, Faget-Agius C, et al. A structural equation modelling approach to explore the determinants of quality of life in schizophrenia. A Struct Equ Model Approach Explor Determ Qual Life Schizophr. 2016;171(1–3):SP–27–34.
   Google Scholar
• Eack SM, Newhill CE. Psychiatric symptoms and quality of life in schizophrenia: a meta-analysis. Schizophr Bull. 2007;33(5):1225–1237. doi:10.1093/schbul/sbl07117204532
   PubMed Web of Science ®Google Scholar
• Savill M, Orfanos S, Reininghaus U, Wykes T, Bentall R, Priebe S. The relationship between experiential deficits of negative symptoms and subjective quality of life in schizophrenia. Schizophr Res. 2016;176:387–391. doi:10.1016/j.schres.2016.06.01727328889
   PubMed Web of Science ®Google Scholar
• Narvaez JM, Twamley EW, McKibbin CL, Heaton RK, Patterson TL. Subjective and objective quality of life in schizophrenia. Schizophr Res. 2008;98(1–3):201–208. doi:10.1016/j.schres.2007.09.00117919890
   PubMed Web of Science ®Google Scholar
• Kirkpatrick B, Fenton WS, Carpenter WT, Marder SR. The NIMH-MATRICS consensus statement on negative symptoms. Schizophr Bull. 2006;32(2):214–219. doi:10.1093/schbul/sbj05316481659
   PubMed Web of Science ®Google Scholar
• Teng E, Tassniyom K, Lu P. Reduced quality of life ratings in mild cognitive impairment: analyses of subject and informant responses (P04.208). Neurology. 2012;78(MeetingAbstracts 1):P04.208-P04.208. doi:10.1212/WNL.78.1_MeetingAbstracts.P04.208
   Google Scholar
• Logsdon RG, Gibbons LE, McCurry SM, Teri L. Assessing quality of life in older adults with cognitive impairment. Psychosom Med. 2002;64(3):510–519. doi:10.1097/00006842-200205000-0001612021425
   PubMed Web of Science ®Google Scholar
• Alptekin K, Akvardar Y, Kivircik Akdede BB, et al. Is quality of life associated with cognitive impairment in schizophrenia? Prog Neuropsychopharmacol Biol Psychiatry. 2005;29(2):239–244. doi:10.1016/j.pnpbp.2004.11.00615694230
   PubMed Web of Science ®Google Scholar
• Savilla K, Kettler L, Galletly C. Relationships between cognitive deficits, symptoms and quality of life in schizophrenia. Aust N Z J Psychiatry. 2008;42(6):496–504. doi:10.1080/0004867080205051218465376
   PubMed Web of Science ®Google Scholar
• Tolman AW, Kurtz MM. Neurocognitive predictors of objective and subjective quality of life in individuals with schizophrenia: a meta-analytic investigation. Schizophr Bull. 2012;38:304–315. doi:10.1093/schbul/sbq07720624752
   PubMed Web of Science ®Google Scholar
• Caqueo-Urízar A, Boyer L, Baumstarck K, Gilman SE. Subjective perceptions of cognitive deficits and their influences on quality of life among patients with schizophrenia. Qual Life Res. 2015;24:2753–2760. doi:10.1007/s11136-015-1019-226038220
   PubMed Web of Science ®Google Scholar
• Takeda T, Nakataki M, Ohta M, et al. Negative and positive self-thoughts predict subjective quality of life in people with schizophrenia. Neuropsychiatr Dis Treat. 2019;Volume 15:293–301. doi:10.2147/NDT.S190381
   Web of Science ®Google Scholar
• Casey DA, Vickar G, Shihabuddin L, Northcott C, Rodriguez M. Schizophrenia: medical illness, mortality, and aging. Int J Psychiatry Med. 2011;41:245–251. doi:10.2190/pm.41.3.c22073763
   PubMed Web of Science ®Google Scholar
• Lee J, Nurjono M, Wong A, Salim A. Prevalence of metabolic syndrome among patients with schizophrenia in Singapore. Ann Acad Med Singapore. 2012;41(10):457–462.23138143
   PubMed Web of Science ®Google Scholar
• Fagiolini A, Goracci A. The effects of undertreated chronic medical illnesses in patients with severe mental disorders. J Clin Psychiatry. 2009;70:22–29. doi:10.4088/JCP.7075su1c.0419570498
   PubMed Web of Science ®Google Scholar
• Sexton E, King-Kallimanis BL, Layte R, Hickey A. How does chronic disease status affect CASP quality of life at older ages? Examining the WHO ICF disability domains as mediators of this relationship. Aging Ment Heal. 2015;19:622–633. doi:10.1080/13607863.2014.955457
   PubMed Web of Science ®Google Scholar
• Bitter I, Czobor P, Dossenbach M, Volavka J. Effectiveness of clozapine, olanzapine, quetiapine, risperidone, and haloperidol monotherapy in reducing hostile and aggressive behavior in outpatients treated for schizophrenia: a prospective naturalistic study (IC-SOHO). Eur Psychiatry. 2005;20(5–6):403–408. doi:10.1016/j.eurpsy.2005.01.00916084068
   PubMed Web of Science ®Google Scholar
• Lozano ÓM, Rojas AJ, Fernández Calderón F. Psychiatric comorbidity and severity of dependence on substance users: how it impacts on their health-related quality of life? J Ment Heal. 2017;26:119–126. doi:10.1080/09638237.2016.1177771
   PubMed Web of Science ®Google Scholar
• Alshowkan A, Curtis J, White Y. Quality of life for people with schizophrenia : a literature review. Arab J Psychiatry. 2012;23(2):122–131.
   Google Scholar
• Strassnig M, Brar JS, Ganguli R. Body mass index and quality of life in community-dwelling patients with schizophrenia. Schizophr Res. 2003;62:73–76. doi:10.1016/S0920-9964(02)00441-312765746
   PubMed Web of Science ®Google Scholar
• Yu ZB, Han SP, Cao XG, Guo XR. Intelligence in relation to obesity: a systematic review and meta-analysis. Obes Rev. 2010. doi:10.1111/j.1467-789X.2009.00656.x
   Web of Science ®Google Scholar
• Kontodimopoulos N, Pappa E, Niakas D, Yfantopoulos J, Dimitrakaki C, Tountas Y. Validity of the EuroQoL (EQ-5D) instrument in a Greek general population. Value Heal. 2008;11:1162–1169. doi:10.1111/j.1524-4733.2008.00356.x
   PubMed Web of Science ®Google Scholar
• Khanna R, Jariwala K, Bentley JP. Psychometric properties of the EuroQol Five Dimensional Questionnaire (EQ-5D-3L) in caregivers of autistic children. Qual Life Res. 2013;22:2909–2920. doi:10.1007/s11136-013-0423-823615959
   PubMed Web of Science ®Google Scholar
• Brazier J, Deverill M. A checklist for judging preference-based measures of health related quality of life: learning from psychometrics. Health Econ. 1999;8(1):41–51.10082142
   PubMed Web of Science ®Google Scholar
• Perez J, Russo DA, Stochl J, et al. Comparison of high and low intensity contact between secondary and primary care to detect people at ultra-high risk for psychosis: study protocol for a theory-based, cluster randomized controlled trial. Trials. 2013;14(1):222. doi:10.1186/1745-6215-14-22223866815
   PubMed Web of Science ®Google Scholar
• Ruggeri M, Nosè M, Bonetto C, et al. Changes and predictors of change in objective and subjective quality of life: multiwave follow-up study in community psychiatric practice. Br J Psychiatry. 2005;187:121–130. doi:10.1192/bjp.187.2.12116055822
   PubMed Web of Science ®Google Scholar
• Zeng Y, Zhou Y, Lin J, Zhou Y, Yu J. Generic and disease-specific quality of life and its predictors among Chinese inpatients with schizophrenia. Psychiatry Res. 2015;228(3):724–728. doi:10.1016/j.psychres.2015.05.03326077848
   PubMed Web of Science ®Google Scholar